Dopamine agent (DrugBank: Dopamine)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 6 | Parkinson disease | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03151460 (ClinicalTrials.gov) | September 2014 | 9/5/2017 | Dopaminergic Modulation of Declarative Memory | Dopaminergic Modulation of Declarative Memory | Parkinson's Disease | Drug: Dopamine Agent | I.R.C.C.S. Fondazione Santa Lucia | NULL | Completed | N/A | N/A | All | 40 | Phase 4 | Italy |